Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-005570

Watanabe Todd sold 19,833 shares at $25.50 ($505,710)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Watanabe Todd

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-02 Sale : show line 1 in the form 10b5-1 −19,833 $25.50 $505,710 721,306 D
Open-market sales · 19,833 sh · avg $25.50 · $505,710
Loading xslF345X05/wk-form4_1770251138.xml…